FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA OKs Galderma Dermatitis Drug Nemluvio

[ Price : $8.95]

FDA approves Galdermas Nemluvio to treat some dermatitis patients aged 12 and older.

Alcon Recalls Systane Ultra PF Eye Drops

[ Price : $8.95]

FDA says Alcon recalled one lot of Systane Ultra PF eye drops due to potential fungal contamination.

FDA OKs Arrays Braftovi for Some Cancers

[ Price : $8.95]

FDA approves Array BioPharmas Braftovi to treat some patients with metastatic colorectal cancer with a specific mutation.

Ionis Spinraza Approved by FDA for SMA

[ Price : $8.95]

FDA approves Ionis Spinraza as the first drug approved to treat children and adults with spinal muscular atrophy.

CGMP Violations in Micro Orgo Chem Inspection

[ Price : $8.95]

FDA warns Indias Micro Orgo Chem about CGMP deviations in its production of active pharmaceutical ingredients.

Bhargava Phytolab CGMP Violations

[ Price : $8.95]

FDA warns Indias Bhargava Phytolab about CGMP issues in its manufacturing of finished drugs and active pharmaceutical ingredients....

FDA Wants Labeling Changes for Buprenorphine

[ Price : $8.95]

FDA recommends that companies making transmucosal buprenorphine drugs indicated to treat opioid dependence revise the labeling to ...

Global Unique Device ID Database Guidance

[ Price : $8.95]

FDA publishes an updated Global Unique Device Identification Database guidance.

FDA Approves Novo Hemophilia Prophylaxis Drug

[ Price : $8.95]

FDA approves Novo Nordisks Alhemo as a prophylaxis for some hemophilia patients.

New Sleep Apnea Indication for Lillys Zepbound

[ Price : $8.95]

FDA approves a new indication for Lillys Zepbound to treat some obese patients with obstructive sleep apnea.